CDC IXIS INNOVATION
CDC IXIS INNOVATION
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2004-07-21 | NewStar Financial | CDC IXIS Innovation investment in Debt Financing - NewStar Financial | 450 M USD |
| 2004-07-08 | OneAccess | CDC IXIS Innovation investment in Series C - OneAccess | 7.5 M EUR |
| 2003-03-05 | NEMOPTIC | CDC IXIS Innovation investment in Series C - NEMOPTIC | 12 M USD |
| 2002-12-05 | Catalyst Biosciences | CDC IXIS Innovation investment in Venture Round - Catalyst Biosciences | 46 M USD |
| 2002-11-05 | Kuros Biosciences | CDC IXIS Innovation investment in Series A - Kuros Biosciences | 7 M EUR |
| 1999-08-05 | NEMOPTIC | CDC IXIS Innovation investment in Series A - NEMOPTIC | 2.3 M EUR |
More informations about "CDC IXIS Innovation"
CDC IXIS Innovation | Institution Profile - Private Equity International
CDC IXIS Innovation overview CDC Innovation is a venture capital firm based in Paris and has presence in the Silicon valley and Geneva. CDC Innovation primarily makes investments of between EUR 6 million to EUR 10 million in both early stage and late stage firms in information technologies and life sciences sectors.See details»
CDC IXIS Innovation - Investments, Portfolio & Company Exits
Jul 21, 2004 CDC IXIS Innovation has invested in Catalyst Biosciences on Jul 21, 2004. This investment - Venture Round - Catalyst Biosciences - was valued at . obfuscated. obfuscated. Announced Date . Organization Name ... Which industries has this organization had the most exits in? Show .See details»
CDC-IXIS Innovation investment portfolio - PitchBook
Dec 1, 2001 CDC-IXIS Innovation has made numerous investments in companies like 6Wind and QoSmetrics within the Business/Productivity Software industry. What has CDC-IXIS Innovation invested in recently? CDC-IXIS Innovation's latest investment was on 18-Feb-2004 in 6Wind , a company within the Business/Productivity Software industry.See details»
CDC IXIS Innovation - Crunchbase
CDC IXIS Innovation is a venture capital firm investing in tech and life sciences companies.See details»
CDC IXIS Innovation — 6 Deals, 5 Portfolio startups, Statistics ...
Opposing the other organizations, this CDC IXIS Innovation works on 21 percentage points more the average amount of lead investments. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2017.See details»
Trusted Insight | CDC IXIS Innovation Investment Firm Profile
CDC IXIS Innovation investment firm profile page on Trusted Insight - the platform for institutional investors to discover investment jobs, talent, alternative investment news, syndicates and top investment managers rankingsSee details»
CDC IXIS Innovation - fintechwithoutborders.org
CDC IXIS Innovation Investments, Sectors and Contact Details. CDC IXIS Innovation. CDC IXIS Innovation. Location. France. Investment Stage • Early Stage Venture ...See details»
CDC Ixis Innovation - BioCentury Company Profiles - BCIQ
CDC Ixis Innovation - BioCentury Company Profiles for the biopharma industrySee details»
Daniel Balmisse - Cathay Innovation
He was appointed a member of the Management Board and COO of CDC Ixis Innovation in 2002. Daniel began his professional career in 1988 with engineering and management positions in the telecommunications industry, first at the …See details»
CDC TARGETS E450M FOR FRENCH BUYOUTS
Feb 1, 2002 In November CDC-Innovation Partners, the high tech venture capital arm of CDC-IXIS Private Equity, announced an initial closing at e102 million, of its third fund, Science et Innovation 2001. Fondinvest, CDC IXIS’s fund-of-funds business is also raising new capital for its third generation of primary and secondary fund-of-funds. Fondinvest ...See details»
CDC IXIS North America Inc. - MRRS Decision - OSC
Jun 10, 2003 (c) CDC Financial Products Inc. and CDCFunding Corp., which transact capital markets and borrowingactivities in the United States and which also benefit froma guarantee from CDC IXIS. 5. As subsidiaries of a French bank, the Applicantand each of the Subsidiaries are subject to regulation bythe Banque de France and to direct oversight by the …See details»
CDC IXIS Asset Management reorganises teams - Financial News
Jan 25, 2002 CDC IXIS Asset Management is reorganising its investment teams in Paris in a move to strengthen team management and develop its international and retail distribution activities. Roland Calvo, currently manager of strategy and research and chairman of the investment strategic committee, has been appointed to the newly created role of chief …See details»
CDC IXIS: 'Independent Thinking' - Adweek
An effort was made to “convey a sense of innovation, intelligence and independence in the ads,” according to Pilibosian. CDC IXIS Asset Management Advisors is a subsidiary of Paris-based CDC ...See details»
Fund profile - CDC Ixis - IR Impact
Mar 31, 2001 CDC Ixis in numbers Capitalized at g5 bn; 5,000 employees worldwide. $330 bn worth of assets under management worldwide, of which 30 percent is in equity, 54 percent in bonds, 7 percent in real estate and the rest invested in money markets. ... Fund manager profile: ‘We put a lot of emphasis on innovation,’ says Heptagon Capital’s ...See details»
Fund profile - CDC Ixis - IR Magazine
But that's not how CDC Ixis sees it. The newly formed French banking and investment group has almost half its $330 bn in assets invested in North America and has every intention of expanding there. The new group is, for the time being, a wholly-owned offshoot of the French government-owned CDC, the Caisse des Depots et Consignations.See details»
About the Innovation Team | Office of Science (OS) | CDC
Aug 9, 2024 Coordinating CDC's Small Business Innovation Research Program which funds U.S.-based small businesses to engage in Federal Research/Research and Development (R/R&D) with the potential for technology commercialization. CDC's SBIR Program targets innovations in diagnostics, data science (e.g., artificial intelligence (AI) and machine learning), …See details»
Innovation & Research | Global Health | CDC - Centers for Disease ...
Jan 15, 2025 Game-changing developments. In 2024, the malaria vaccine CDC developed with Kenya Medical Research Institute was officially added to routine immunization programs in Cameroon and Burkina Faso, marking a historic milestone in the global fight against malaria. CDC laboratory scientists are also working with NIH to develop a new vaccine against the deadly …See details»
Viventures Partners SA - Crunchbase Investor Profile & Investments
OneAccess raised €7,500,000 / Series C from CDC IXIS Innovation and 3 other investors . Discover more funding rounds . ... 6,608 Number of Organizations • $44.1B Total Funding Amount • 786 Number of Investors. Track . Europe, Middle …See details»
About Technology Transfer and Innovation | Office of Science (OS) …
Sep 30, 2024 The Innovation Team promotes innovative approaches and solutions to advance public health across the agency. They advance innovation through: Small Business Innovation Research (SBIR) Program. Academic collaborations. Training. Data science. Citizen science. Challenges. ContestsSee details»